December 30, 2025/
Chronic Kidney Disease (CKD) significantly alters the pharmacokinetics and pharmacodynamics of many drugs, making medication management a critical aspect of patient care. In the context of...
ALVigiLance is a dedicated pharmacovigilance platform designed to support the healthcare team in ensuring safer medication use. Our mission is simple yet vital: to provide trusted insights, practical tools, and up-to-date resources that empower healthcare professionals to identify, prevent, and manage adverse drug reactions (ADRs).
Simplified, practical guides on drug safety and monitoring.
Real-world examples to strengthen your clinical decision-making.
Summaries of global drug warnings and regulatory actions.
Strategies for adverse event reporting, risk management, and patient counseling.
To create a proactive community of healthcare providers who champion medication safety and improve patient outcomes through shared knowledge and vigilance.
Medication safety is everyone’s responsibility. Explore, learn, and engage with ALVigiLance — because together, we can reduce risks and save lives.
Chronic Kidney Disease (CKD) significantly alters the pharmacokinetics and pharmacodynamics of many drugs, making medication management a critical aspect of patient care. In the context of...
Nutrivigilance is the systematic monitoring, assessment, and prevention of adverse effects related to the use of food supplements, fortified foods, and other nutritional products. It is the pharmacovigilance equivalent...
This document is the "EDA Renal Anaemia Guidance to Good Pharmacy Practice" (Code: EDREX:GU.CAP.Care.016, Version: 2025), issued by the Egyptian Drug Authority's Central Administration of Pharmaceutical Care. It...
